Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway.
Zenz, Thorsten
Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway. [electronic resource] - Cell cycle (Georgetown, Tex.) Dec 2008 - 3810-4 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1551-4005
10.4161/cc.7.24.7245 doi
Ataxia Telangiectasia Mutated Proteins
Cell Cycle Proteins--genetics
Chromosomes, Human, Pair 17
DNA Damage
DNA-Binding Proteins--genetics
Drug Resistance, Neoplasm
Gene Deletion
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
MicroRNAs--genetics
Protein Serine-Threonine Kinases--genetics
Survival Analysis
Tumor Suppressor Protein p53--genetics
Tumor Suppressor Proteins--genetics
Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway. [electronic resource] - Cell cycle (Georgetown, Tex.) Dec 2008 - 3810-4 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1551-4005
10.4161/cc.7.24.7245 doi
Ataxia Telangiectasia Mutated Proteins
Cell Cycle Proteins--genetics
Chromosomes, Human, Pair 17
DNA Damage
DNA-Binding Proteins--genetics
Drug Resistance, Neoplasm
Gene Deletion
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
MicroRNAs--genetics
Protein Serine-Threonine Kinases--genetics
Survival Analysis
Tumor Suppressor Protein p53--genetics
Tumor Suppressor Proteins--genetics